Drug intelligence / Profile preview

740 Y-P

Development stage
Preclinical
Modality
Peptides, Small Molecules
Administration
In Vitro (cell Culture), Intraperitoneal Injection (animal Studies)
01

Overview

**740 Y-P is a synthetic cell-permeable phosphopeptide that acts as a potent activator of phosphoinositide 3-kinase (PI3K).** It is designed to mimic the phosphorylated tyrosine motif found in the platelet-derived growth factor receptor (PDGFR), specifically at position Tyr-740. The peptide sequence includes an Antennapedia protein transduction domain to facilitate cellular uptake. Mechanistically, it binds to the SH2 domains of the p85 regulatory subunit of PI3K and stimulates PI3K activity both in vitro and in vivo. This activation leads to downstream signaling through pathways such as PI3K/Akt/mTOR and can stimulate mitogenesis even at low concentrations[1][2][5][9]. In research models, it has been shown to increase phosphorylation of AKT and PI3K and reduce reactive oxygen species levels in neuronal tissue[5]. Its primary use is as a biochemical tool for studying signal transduction related to cell proliferation, survival, autophagy modulation, apoptosis inhibition, and neuroprotection. It is not approved for clinical or therapeutic use; all applications are limited strictly to laboratory research.

Other names
PDGFR 740Y-PPDGFR740Y-PPDGFR-740Y-PY-P 740Y-P740Y-P-740
02

Targets

PIK3R1 (Phosphatidylinositol 4-phosphate 3-kinase regulatory subunit alpha)

Beyond the preview

Go deeper on 740 Y-P.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 740 Y-P.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call